key: cord-0931679-vfaadced
authors: Orilisi, Giulia; Mascitti, Marco; Togni, Lucrezia; Monterubbianesi, Riccardo; Tosco, Vincenzo; Vitiello, Flavia; Santarelli, Andrea; Putignano, Angelo; Orsini, Giovanna
title: Oral Manifestations of COVID-19 in Hospitalized Patients: A Systematic Review
date: 2021-11-27
journal: Int J Environ Res Public Health
DOI: 10.3390/ijerph182312511
sha: 2200dccd995889de5648c4ec11c57bbf51e5753f
doc_id: 931679
cord_uid: vfaadced

Background: COVID-19 disease first appeared in 2019 and quickly spread worldwide, causing a global pandemic. The oral cavity represents a target of SARS-CoV-2, and oral lesions are observed in both non-hospitalized and hospitalized patients. This systematic review aims to investigate the frequency of oral manifestations in COVID-19 hospitalized patients. Methods: An electronic search was conducted in PubMed, Scopus, and Web of Science databases, including articles published up to September 2021. The review protocol was based on PRISMA-P. The risk of bias of the studies was assessed using the Joana Briggs Institute. The certainty of evidence was assessed using the GRADE instrument. Results: Fifty-nine articles were included: 19 case reports, 17 case series, 2 case-control studies, 13 cross-sectional studies, 4 observational studies, and 4 retrospective studies. Oral ulcers, cheilitis, and tongue lesions were more common in patients before hospitalization, while perioral pressure ulcers, macroglossia, blisters, and oral candidiasis were more recurrent in patients during hospitalization. The first could be related directly to COVID-19, while the latter could be caused by medical devices, treatments, prone position, and immunological impairment. Conclusions: An accurate oral examination during the hospital admission of all confirmed COVID-19 cases is encouraged to recognize oral early manifestations and to apply appropriate treatments.

The outbreak of novel coronavirus SARS-CoV-2 has created a global crisis and challenged healthcare systems across the world [1] . It was first identified in Wuhan, China, on 31 December 2019, in association with a severe human respiratory disease . On 30 January 2020, the World Health Organization (WHO) declared the COVID-19 infection as a Public Health Emergency of International Concern.

SARS-CoV-2 is an enveloped, positive-sense, single-stranded RNA virus with multiple spikes on the surface and a genome size of approximately 26-32 kilobases. Fever, dyspnea, body aches, and dry cough are the most common symptoms [2] , but severe cases can develop pneumonia, severe acute respiratory syndrome, and kidney failure, representing a life-threatening condition [3, 4] . Most patients display moderate symptoms (80%), while 20% of them may develop a severe disease and 5% may become critically ill, developing pneumonia or acute respiratory distress syndrome, which requires mechanical ventilation and intensive care unit hospitalization [5] . SARS-CoV-2 mainly spreads through respiratory droplets, aerosols, contact, and fomites [6] [7] [8] [9] .

Studies were selected by title and abstract, and full-text screening. Articles were included if they reported oral manifestations in hospitalized patients with COVID-19 infection.

The full-text articles of all potential studies were evaluated according to the eligibility criteria. The inclusion criteria were: (1) hospitalized patient affected by COVID-19, confirmed through RT-PCR testing; (2) articles reporting oral manifestation associated with and (3) studies published in the English language. The exclusion criteria were: (1) not-confirmed COVID-19 cases; (2) duplicate studies and data; and (3) full-text not accessible. There were no disagreements during the article selection process.

The primary outcome was to highlight the oral signs and symptoms that can occur in hospitalized patients affected by A flow diagram detailing the process is presented in Figure 1 . 

The risk of bias of each study was assessed by two blinded reviewers using the Joanna Briggs Institute (JBI) critical appraisal checklist for case reports [29, 30] . The score system was agreed by all reviewers before the critical appraisal assessments, and studies were classified according to the following categories: (a) low risk of bias, if the studies reached more than 70% scores of "yes"; (b) moderate risk of bias, if "yes" scores ranged from 50% to 69%; and (c) high risk of bias, if "yes" scores were less than 49%. Data are reported in Supplementary Materials (Table S1 ). Full-text articles assessed for eligibility (n = 187)

Full-text articles excluded, with reasons: Studies reporting oral lesions in non-hospitalized patients or studies in which patient status is not specified (n = 58); Studies reporting dental practice or dental management during COVID-19 (n= 11); Data non individualized for oral lesions (n= 24); Reviews, letters to editor without presenting case report or case series (n= 31); Other reasons (n= 4). 

The risk of bias of each study was assessed by two blinded reviewers using the Joanna Briggs Institute (JBI) critical appraisal checklist for case reports [29, 30] . The score system was agreed by all reviewers before the critical appraisal assessments, and studies were classified according to the following categories: (a) low risk of bias, if the studies reached more than 70% scores of "yes"; (b) moderate risk of bias, if "yes" scores ranged from 50% to 69%; and (c) high risk of bias, if "yes" scores were less than 49%. Data are reported in Supplementary Materials (Table S1 ).

The evidence levels of the selected studies were assessed using the GRADE instrument (http://gradepro.org (accessed on 28 October 2021)) [31] . The certainty of evidence was rated for oral lesions prevalence in hospitalized patient. This assessment was based on study design, risk of bias, inconsistency, indirectness, imprecision, and other considerations. Evidence quality was characterized as high, moderate, low, or very low [32] . Data are reported in Supplementary Materials (Table S2 ).

Descriptive statistical analysis was conducted by grouping and comparing data using Microsoft Excel software (2019, Microsoft Corporation, Redmond, WA, USA)

A total of 340 studies were identified from databases, and, after removing the duplicate, 193 studies remained for title and abstract screening. A full-text reading was conducted on 187 studies. A total of 128 studies were excluded according to the eligibility criteria. Therefore, 59 studies were selected: 19 case reports, 17 case series, 2 case-control studies, 13 cross-sectional studies, 4 observational studies, and 4 retrospective studies (Table S1 ). Due to the lack of available data, case reports and series were also included in this systematic review. Thus, the risk-of-bias of each study was evaluated using the JBI critical appraisal checklist [33] . A flowchart detailing the process is presented in Table S1 .

A total of 35 articles were judged as low risk [21, 26, , 12 as a moderate risk [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] , and 12 as high risk [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] (Table S1 ).

The sample consisted of 1219 patients, of which there were 456 men (37.4%), 374 women (30.7%), and 389 patients with no specified sex (31.9%), with a mean age of 50.8 years. Results from each selected article were subdivided into "oral lesions appeared before hospital admission" and "oral lesions appeared during hospitalization". The studies were set in two tables (Tables 1 and 2) , reporting the following data: first author's name and year of publication, study design, sample size and gender, mean age, medical history, oral manifestations, time of onset, affected site, treatment of COVID-19, treatment of oral manifestation, disease duration, reported diagnosis, and the risk of bias.

Moreover, data were categorized and described according to the following eight groups: (1) tongue lesions; (2) ulcerative and erosive lesions; (3) aphthous-like lesions; (4) vesiculobullous lesions; (5) lip lesions; (6) functional disorders; (7) candidiasis; and (8) non-specific lesions (mucositis). 

Tongue lesions appearing before hospital admission were reported in 14 studies [37, 38, 43, 51, 61, 63, 65, 70, 71, 74, 81, [87] [88] [89] , while 14 articles showed that tongue manifestations occurred during hospitalization [21, 34, 36, 39, 48, 54, 59, 60, 66, 69, 70, 82, 84] . The sample consisted of 172 males (age: 57.0 ± 15.1) and 155 females (age: 46.1 ± 22.1). Moreover, 135 patients with no specified sex and mean age were included.

Before hospitalization, white tongue, necrosis of the dorsal tongue, glossitis, geographic and fissured tongue, strawberry tongue, and depapillation of the tongue were the most common lesions diagnosed, directly related to SARS-CoV-2. One patient with a complex medical history showed a 1.5 × 1.5 cm ulcer in the right border of the tongue, while another patient reported a mucopurulent membrane in the anterior dorsal tongue [37] . Only three studies that reported tongue lesions referred to Kawasaki-like disease, potentially associated with COVID-19 [38, 51, 65] .

During hospital admission, the main SARS-CoV-2 related lesions were tongue ulcers, especially in ICU patients [21] . Moreover, white plaque on tongue dorsum, geographic tongue, tongue redness, fissured tongue, and macroglossia were reported [35, 54, 66] . Macroglossia was reported in two patients who experienced prolonged pronation cycles for several days. Andrews et al. suggested 10 days of methylprednisolone in addition to a bite block to prevent this complication [35] ; on the contrary, according to Mascitti et al., macroglossia could be referred to acute lymphatic and vascular obstruction due to COVID-19-related inflammatory response [54] .

Ulcerative and erosive lesions were frequently present in COVID-19 patients, both before and during hospital admission. In particular, 14 studies reported that lesions appeared during hospitalization [21, 34, 36, 37, 42, 45, 47, 48, 52, 57, 64, 69, 70, 82] , while 6 articles referred to lesions that emerged before hospitalization [36] [37] [38] 41, 61, 70] . The sample consisted of 111 males (age: 56.7 ± 15.3) and 90 females (age: 53.2 ± 22.4). Moreover, 123 patients with no specified sex and age were included.

Before and during hospitalization, ulcerative and erosive lesions were the most common orofacial manifestations of COVID-19. The ulcers emerged after a latency time of 4 to 7 days after the onset of COVID-19 symptoms, and most of them were diagnosed upon hospital admission. Only in one case did small oral ulcers appear 40 days after a COVID-19 positive test [42] . Some patients displayed painful herpetic and hemorrhagic ulcers with irregular margins, which were variable in size and number. Ulcers that appeared before hospital admission were located on the hard palate and lips, while the lesions that occurred during hospitalization mainly affected the tongue dorsum, lips, and buccal mucosa.

Some authors suggested different factors involved in the development of ulcerative and erosive lesions [12, 41, 60, 61, 91] . Ulcers could be related directly to SARS-CoV-2 infection or could be caused by drugs, vasculitis, or thrombotic vasculopathy secondary to COVID-19 [34, 41] . Oral ulcerative lesions and erosive plaques appeared a few days after the onset of respiratory symptoms and worsened during hospitalization, due to persistent immunological impairment, and lesions did not heal after SARS-CoV-2 eradication [47] . In four ICU patients, the authors suggested that oral ulcers could be caused by medical devices during the prone positioning phases [21, 57] . A wide range of therapies has been used for oral ulcers, including drugs (e.g., dexamethasone, tetracycline) and photobiomodulation therapies [37, 57, 64] .

Aphthous-like lesions were reported in four studies, affecting six minors and three adults (>50 years). Moreover, aphthous-like lesions were showed in 78 cases with various oral signs and symptoms associated with COVID-19 [88] . Lesions were mainly related to COVID-19, probably due to the distribution of the ACE2 receptor on the oral mucosae [11, 86] , although one patient with minor aphthous ulcers was diagnosed with Sweet syndrome related to COVID-19 [62] . Stress and immunosuppression secondary to COVID-19 infection could be other possible reasons of these lesions [92] .

Vesiculobullous lesions, including herpetiform lesions, angina bullosa-like lesions, and oral blisters, were described in three studies [26, 46, 53, 70] . Carreras-Presas et al. presented a 65-year-old female with lip blisters and desquamative gingivitis, occurring 22 days after viral infection. These lesions seem to be caused by COVID-19 through mechanisms shared with others virus, such as Herpes Simplex Virus-1 (HSV-1)-related gingivostomatitis [26] .

Favia et al. detected oral blisters in 19 hospitalized patients (15.4%) that appeared during the first week after the onset of general symptoms and were mainly located on the tongue and palate [70] . According to the authors, lesions could be related to SARS-CoV-2, medical treatments, and/or poor oral hygiene.

Orolabial recurrent herpes simplex were observed in eight patients [46] . This manifestation was found in at HSV-1-positive patients, suggesting a possible superinfection of herpetic virus with COVID-19.

Thirteen studies showed patients with lip lesions that appeared before hospital admission [37] [38] [39] [40] [41] 43, 51, 63, 65, [70] [71] [72] 74] , and 23 studies during the hospitalization [21, 26, 37, 39, 43, 45, 49, 54, [56] [57] [58] [59] [60] 64, 66, 69, 70, 73, 77, 78, 82, 90] . The reports included 173 males (age: 41.2 ± 25.2), 114 females (age: 52.5 ± 24.3), and 118 patients with no specified sex and age.

Lip lesions included fissured lip, angular cheilitis, and perioral pressure ulcers. Fissured lips have been detected mainly in young patients, who were diagnosed with Kawasaki-like disease related to COVID-19 [39, 40, 51, 54, 65, 71, 72] . Mazzotta et al. described a 9-year-old male with Down syndrome and alopecia areata universalis, presenting glossitis and cheilitis, probably due to the excessive and persistent inflammation that occurred during the interstitial pneumonia with acute respiratory failure [74] . Angular cheilitis, due to stress and immunosuppression, was observed in a 53-year-old man a few days after hospital discharge; after the treatment, this lesion completely disappeared [43] .

Prolonged prone position and endotracheal intubation were the most common risk factors for perioral and lip pressure ulcers, interfering with mechanical ventilation equipment in the critical care setting [21, 49, 56, 58, 59, 66, 73, 77, 78, 90] . Most cases were treated with antimicrobial dressing, debridement of necrotic tissue, and paraffin gauze dressing. Finally, some articles reported lip lesions directly related to COVID-19, which appeared as a mucopurulent membrane with superficial necrosis or swollen lips and disappeared after 10-12 days of treatment [37, 63, 71] .

Functional disorders included xerostomia, viscous saliva, ageusia and dysgeusia, halitosis, burning mouth, masticatory muscle weakness, salivary gland ectasia, temporomandibular article abnormalities, and facial tingling. These disorders were reported by several studies referred to hospitalized patients affected by 34, 43, 76, 82, 88] . The authors suggested these alterations could be directly related to SARS-CoV-2 and could be considered as an early manifestation of COVID-19 infection. Indeed, ACE2 receptors have been found in the taste buds and glandular epithelium, leading to salivary gland dysfunction and salivary flow impairment [93] .

Masticatory muscle weakness, salivary gland ectasia, temporo-mandibular article abnormalities, and facial tingling were reported by Gherlone et al. [48] . The authors suggested that salivary gland ectasia reflected the hyperinflammatory response to SARS-CoV-2, as demonstrated by the significant relationship with C-reactive protein and lactate dehydrogenase levels at hospital admission, and antibiotics use during acute disease.

Candidiasis appeared as white plaques on the dorsum of tongue, gingiva, and palate [43, 44, 66, 70, 75, 80, 81] . The authors suggested it could be related to the long-lasting antibiotic therapy, the deterioration of general status, and poor oral hygiene [80] . Salehi et al. isolated 65 species of Candida spp. (70.7% C. albicans) in a cohort of COVID-19 patients with oropharyngeal candidiasis [75] . Interestingly, Dima et al. reported oral candidiasis with diaper erythema in three newborns positive with COVID-19 [44] . The oral candidiasis in young patients was also reported by Bardellini et al. [81] , describing two cases of oral pseudomembranous candidiasis diagnosed at the hospitalization.

Petechiae, macules, erythema, stomatitis, brown pigmentation, mucositis, enanthema, and desquamative gingivitis were reported in many hospitalized patients [26] . Vascular disorders could cause mucositis in the affected patients. Indeed, Cruz-Tapia et al. described a 51-year-old female with diffuse vascular-like purple macule on the left palate and a papule-plaque on the right palate [68] . Riad et al. described 13 patients affected by mucositis; enanthema of the buccal mucosa, palate, and gingiva; and depapillation of the tongue, at hospitalization. These lesions disappeared after 7-14 days of "Magic mouthwash" and paracetamol and could be related directly to COVID-19 infection [6, 89] . Only one study described a patient affected by oral lichenoid reaction and a case with oral enanthema, directly due to COVID-19 [54] . Marouf et al. suggested that periodontitis was significantly associated with a higher risk of COVID-19 complications, such as ICU admission, assisted ventilation, and the increased markers levels of COVID-19 worse outcome [55] .

A broad spectrum of signs and symptoms were reported in association with COVID-19; however, only a few studies highlighted oral clinical manifestations observed in hospitalized patients. The pathogenesis remains unclear, but some hypotheses have been formulated. Xu et al. showed a higher expression of ACE2 in the oral mucosa, especially on the tongue and in the salivary glands [11] . Thus, the oral cavity might be an anatomical site susceptible to SARS-CoV-2 infection [94] . Consequently, the interaction between SARS-CoV-2 and ACE2 might dysregulate the oral keratinocytes' function, leading to painful oral ulcers [37] . This mechanism could also be the basis of early manifestations of COVID-19, such as taste alteration and xerostomia [95] . The immune response to infection could activate Langerhans cells and lymphocytes, leading to vasculitis and thrombocytopenia, causing oral lesions related to vascular disorders (e.g., petechiae) [19, 41, 92, 96] .

It is still unclear whether oral lesions reflect a direct viral cytopathic effect or represent a consequence of stress, poor oral hygiene, systemic infections, medical treatments, or medical devices used during hospital admission [97] . However, to the best of our knowledge, no attempt has been made to review the available literature regarding oral lesions in hospitalized COVID-19 patients. Therefore, this systematic review is the first to characterizs the patterns of oral lesions that occurred in hospitalized patients affected by COVID-19. As intraoral examination has not yet been considered in the screening of the disease, literature still lacks evidence to better understand the onset of oral manifestations. In this review, the most common oral lesions seen in patients before hospital admission are painful ulcers, cheilitis, and tongue lesions. According to several authors, these lesions are related directly to COVID-19 [36, 37, 88, 89] . Conversely, the most common oral lesions displayed by patients during hospitalization are perioral pressure ulcers, macroglossia, blisters, and oral candidiasis. These lesions may be due to the long-lasting prone position of ICU patients [21, 90] , increased pressure of the endotracheal tubes [59] , prolonged inpatient care [52] , persistent immunological impairment [43, 47] , and medical treatments [80] .

The studies reporting that oral manifestations in COVID-19 are very low, leading to a considerable risk of bias. Most of the eligible studies showed a high risk of bias, due to insufficient simple size, poor methods, or inadequate designs. Case reports and case series have profoundly influenced the medical literature and continue to improve the current knowledge [98] . Although the evidence derived from case series and case reports is very low, a strong recommendation for oral lesions of hospitalized patients, affected by COVID-19, can be provide. Moreover, GRADE literature describes five paradigmatic situations in which a strong recommendation can be made based on low quality evidence, such as a condition of life threatening [99] .

Considering the results of this systematic review, clinicians should consider the oral lesions affecting the hospitalized patients with COVID-19 to ensure an adequate prevention and therapeutic management. Thus, the importance of the oral examination should be emphasized in hospitalized patients with infectious diseases, to encourage the multidisciplinary management of COVID-19 patient.

The new SARS-CoV-2 has become a worldwide sanitary emergency. Understanding the manifestations and progression of COVID-19 is the first step in developing an adequate prevention and treatment management. Although the typical symptoms include fever, shortness of breath, and dry cough, oral lesions have also been reported. The association between oral diseases and SARS-CoV-2 infection is still unclear and is currently poorly investigated.

Based on this systematic review, it could be suggest that: (1) painful oral ulcers, cheilitis, and tongue lesions are more frequent in patients before hospital admission;

(2) perioral pressure ulcers, macroglossia, blisters, and oral candidiasis are more evident in patients during hospitalization; (3) lesions that appeared before hospital admission are mainly related directly to COVID-19; (4) lesions that appeared during hospitalization are mainly associated with medical devices and treatments, prone position, and immunological impairment; (5) all clinicians, during the hospital admission, should be encouraged to perform an accurate oral examination of all confirmed COVID-19 cases to recognize the disease's possible early manifestations; (6) further studies are necessary to establish the pathological significance of oral manifestations during COVID-19.

Supplementary Materials: The following are available online at https://www.mdpi.com/article/ 10.3390/ijerph182312511/s1, Table S1 : Risk of bias in the reported articles, Table S2 : Certainty assessment and grading of the evidence. 

The data presented in this study are available on request from the corresponding author.

A New Coronavirus Associated with Human Respiratory Disease in China

Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19)

Epidemiological and Clinical Characteristics of 99 Cases of 2019 Novel Coronavirus Pneumonia in Wuhan, China: A Descriptive Study

The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19)-China, 2020. China CDC Wkly

Efficacy of Personal Protective Equipment against Coronavirus Transmission via Dental Handpieces

Aerosols Modification with H2O2 Reduces Airborne Contamination by Dental Handpieces

Oral Manifestations of Covid-19-A Literature Review

Efficacy of Personal Protective Equipment and H 2 O 2 -Based Spray against Coronavirus in Dental Setting

Single-Cell RNA-Seq Data Analysis on the Receptor ACE2 Expression Reveals the Potential Risk of Different Human Organs Vulnerable to 2019-NCoV Infection

High Expression of ACE2 Receptor of 2019-NCoV on the Epithelial Cells of Oral Mucosa

Oral Manifestation of Covid-19 as an Inaugural Symptom?

The Prevalence of Olfactory and Gustatory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-Analysis. Otolaryngol. Head Neck Surg

Oral Symptoms Associated with COVID-19 and Their Pathogenic Mechanisms: A Literature Review

Oral Manifestations in Patients with COVID-19: A Living Systematic Review

Dental Public Health Landscape: Challenges, Technological Innovation and Opportunities in the 21st Century and COVID-19 Pandemic

Objective Evaluation of Anosmia and Ageusia in COVID-19 Patients: Single-Center Experience on 72 Cases

Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients

Orofacial Manifestations of COVID-19: A Brief Review of the Published Literature

The Impact of Coronavirus Infectious Disease 19 (COVID-19) on Oral Health. Oral Dis. 2020

Oral Complications of ICU Patients with COVID-19: Case-Series and Review of Two Hundred Ten Cases

Oral Mucosal Lesions and Covid-19: Symptoms and/or Complication?

Are Oral Manifestations Related to SARS-CoV-2 Mediated Hemolysis and Anemia?

COVID-19: Hemoglobin, Iron, and Hypoxia beyond Inflammation. A Narrative Review

Classification of the Cutaneous Manifestations of COVID-19: A Rapid Prospective Nationwide Consensus Study in Spain with 375 Cases

Oral Vesiculobullous Lesions Associated with SARS-CoV-2 Infection

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews

Conducting Systematic Reviews of Association (Etiology): The Joanna Briggs Institute's Approach

GRADE: An Emerging Consensus on Rating Quality of Evidence and Strength of Recommendations

Systems for Grading the Quality of Evidence and the Strength of Recommendations I: Critical Appraisal of Existing Approaches The GRADE Working Group

Methodological Guidance for Systematic Reviews of Observational Epidemiological Studies Reporting Prevalence and Cumulative Incidence Data

Oral Mucosal Lesions in a COVID-19 Patient: New Signs or Secondary Manifestations?

Lingual Compression for Acute Macroglossia in a COVID-19 Positive Patient

Oral Cavity Lesions as a Manifestation of the Novel Virus (COVID-19)

Oral Lesions in Patients with SARS-CoV-2 Infection: Could the Oral Cavity Be a Target Organ? Oral Surg. Oral Med. Oral Pathol. Oral Radiol

Coronavirus Disease 2019-Related Kawasakilike Disease in an Adult: A Case Report

Multisystem Inflammatory Syndrome in Children During the Coronavirus 2019 Pandemic: A Case Series

Kawasaki Disease Features and Myocarditis in a Patient with COVID-19

Oral Erosions and Petechiae during SARS-CoV-2 Infection

Pemphigus Vulgaris After COVID-19: A Case of Induced Autoimmunity. SN Compr

Oral Manifestations Associated with COVID-19. Oral Dis. 2020

First Neonates with Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Romania

Erythema Multiform-like Lesions in a Patient Infected with SARS-CoV-2: A Case Report

To Consider Varicella-like Exanthem Associated with COVID-19, Virus Varicella Zoster and Virus Herpes Simplex Must Be Ruled out. Characterization of Herpetic Lesions in Hospitalized COVID-19 Patients

Persistent Lesions in Oral Cavity after SARS-CoV-2 Infection

Frequent and Persistent Salivary Gland Ectasia and Oral Disease After COVID-19

Prone Position Pressure Sores in the COVID-19 Pandemic: The Madrid Experience

Erythema Multiforme-like Eruption in Patients with COVID-19 Infection: Clinical and Histological Findings

COVID-19 and Kawasaki Disease: Novel Virus and Novel Case

COVID-19-Associated Herpetic Gingivostomatitis

Reply to "Varicellalike Exanthem as a Specific COVID-19-Associated Skin Manifestation: Multicenter Case Series of 22 Patients": To Consider Varicella-like Exanthem Associated with COVID-19, Virus Varicella Zoster and Virus Herpes Simplex Must Be Ruled Out

Clinical Cutaneous Features of Patients Infected With SARS-CoV-2 Hospitalized for Pneumonia: A Cross-Sectional Study

Association between Periodontitis and Severity of COVID-19 Infection: A Case-Control Study

Facial Pressure Ulcers in COVID-19 Patients Undergoing Prone Positioning: How to Prevent an Underestimated Epidemic?

A Combination of Phototherapy Modalities for Extensive Lip Lesions in a Patient with SARS-CoV-2 Infection

Pression-Induced Facial Ulcers by Prone Position for COVID-19 Mechanical Ventilation

Eruptions and Related Clinical Course among 296 Hospitalized Adults with Confirmed COVID-19

Skin and Mucosal Damage in Patients Diagnosed With COVID-19: A Case Report

Letter to Editor: Oral Lesions in a Patient with Covid-19

Coronavirus 19 Presenting with Atypical Sweet's Syndrome

Melkersson-Rosenthal Syndrome Induced by COVID-19

Photobiomodulation Therapy and Antimicrobial Photodynamic Therapy for Orofacial Lesions in Patients with COVID-19: A Case Series

An Outbreak of Severe Kawasaki-like Disease at the Italian Epicentre of the SARS-CoV-2 Epidemic: An Observational Cohort Study

Facial Pressure Ulcers in a COVID-19 50-Year-Old Female Intubated Patient

Detection of SARS-CoV-2 in Saliva and Characterization of Oral Symptoms in COVID-19 Patients

Oral Mucosal Lesions in Patients with SARS-CoV-2 Infection. Report of Four Cases. Are They a True Sign of COVID-19 Disease? Spec. Care Dent

Changes in the Oral Cavity of a Patient after Suffering from Coronavirus Infection COVID-19: A Clinical Case

Covid-19 Symptomatic Patients with Oral Lesions: Clinical and Histopathological Study on 123 Cases of the University Hospital Policlinic of Bari with a Purpose of a New Classification

Oral Manifestations of COVID-2019-Related Multisystem Inflammatory Syndrome in Children: A Review of 47 Pediatric Patients

Erythema Multiforme and Kawasaki Disease Associated with COVID-19 Infection in Children

Medical Device-Related Pressure Injuries During the COVID-19 Pandemic

Acral Rash in a Child with COVID-19

Oropharyngeal Candidiasis in Hospitalised COVID-19 Patients from Iran: Species Identification and Antifungal Susceptibility Pattern

SARS-CoV-2 and Oral Manifestation: An Observational, Human Study

Medical Device Related Pressure Ulcer of the Lip in a Patient with COVID-19: Case Report and Review of the Literature

Perioral Pressure Ulcers in Patients with COVID-19 Requiring Invasive Mechanical Ventilation

Cutaneous Manifestations in Hospitalized Patients Diagnosed as COVID-19

Adraktas, A. Initial Real-Life Experience from a Designated COVID-19 Centre in Athens, Greece: A Proposed Therapeutic Algorithm. SN Compr

Non-Specific Oral and Cutaneous Manifestations of Coronavirus Disease 2019 in Children

Oral Manifestations of COVID-19 Patients: An Online Survey of the Egyptian Population

Comment on "Cutaneous Manifestations in COVID-19: A First Perspective" by Recalcati S

Analysis of Tongue Color-Associated Features among Patients with PCR-Confirmed COVID-19 Infection in Ukraine. Pesqui. Bras. Odontopediatria Clínica Integr

Enanthem in Patients With COVID-19 and Skin Rash

Increased odds ratio for COVID-19 in patients with recurrent aphthous stomatitis

Tongue and Floor of Mouth Swelling: A Potential Rare Manifestation of COVID-19

Prevalence of Mucocutaneous Manifestations in 666 Patients with COVID-19 in a Field Hospital in Spain: Oral and Palmoplantar Findings

The Manifestation of Oral Mucositis in COVID-19 Patients: A Case-Series

Facial Pressure Injuries from Prone Positioning in the COVID-19 Era

Unique Skin Manifestations of COVID-19: Is Drug Eruption Specific to COVID-19?

Oral Manifestations of COVID-19 Disease: A Review Article

COVID 19-An Update on Oral Changes

Association of Viral Infections With Oral Cavity Lesions: Role of SARS-CoV-2 Infection

How to Deal with Coronavirus Disease 2019: A Comprehensive Narrative Review about Oral Involvement of the Disease

Potential Link between SARS-CoV-2 and Kawasaki Disease: Importance of Dentists for the Diagnosis

Clinical Characteristics of Severe Acute Respiratory Syndrome Coronavirus 2 Reactivation

Methodological Quality and Synthesis of Case Series and Case Reports

Endocrine Society Guidelines: When the Confidence Cart Goes before the Evidence Horse

Acknowledgments: ECCE-COST ACTION CA 16234 is kindly acknowledged.

The authors declare no conflict of interest.